John L. Lechleiter

John L. Lechleiter is an American chemist and business executive who served as the CEO of Eli Lilly and Company, a major pharmaceutical firm, from 2008 to 2017. Under his leadership, the company focused on developing innovative medicines for conditions like diabetes, cancer, and mental health. He played a key role in advancing research and expanding global operations. Lechleiter has contributed significantly to the pharma industry through his expertise in science and business strategy, fostering advancements in healthcare and medication development.